ENSOL BIOSCIENCES INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,850 KRW | -1.02% |
|
+0.10% | -22.03% |
More news
| 1 day | -1.02% | ||
| 1 week | +0.10% | ||
| Current month | +10.60% | ||
| 1 month | +10.60% | ||
| 3 months | +7.18% | ||
| 6 months | -45.32% | ||
| Current year | -22.03% |
1 week
4 350.00
5 100.00
1 month
4 210.007 640.00
Current year
2 800.007 640.00
1 year
2 800.0014 480.00
3 years
2 800.0018 750.00
5 years
2 800.0022 950.00
10 years
2 800.0022 950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hae-Jin Kim
FOU | Founder | 64 | 01-02-19 |
Eun-Jung Moon
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Nam-Deuk Jeon
BRD | Director/Board Member | 59 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tae-Oh Lee
BRD | Director/Board Member | 67 | - |
Hae-Jin Kim
FOU | Founder | 64 | 01-02-19 |
Eun-Jung Moon
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Ensol Biosciences Inc. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the development and sale of drugs for degenerative disc disease (DDD), osteoarthritis, triple negative breast cancer (TNBC), Alzheimer's disease (AD) and type I diabetes. In addition, it also produces and sells drugs for animal and provides bio big data analysis services. The drugs for Animal include drugs for animal osteoarthritis, as well as animal anticancer, among others. The bio big data analysis services are provided by knowledge-based in silico drug discovery (KISDD) platform and Ensol trans-omics network system (ETONS).
Calendar
2024-05-28
- Investor Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -22.03% | 30.2M | |
| -3.46% | 102B | |
| +1.41% | 96.09B | |
| +2.13% | 22.28B | |
| -15.84% | 21.4B | |
| -9.21% | 18.14B | |
| -39.98% | 17.02B | |
| -14.65% | 16.09B | |
| +4.39% | 13.83B | |
| +31.35% | 11.97B |
- Stock Market
- Equities
- A140610 Stock
